Design Therapeutics Earnings
NASDAQ: DSGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.65+0.16 (+1.39%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 11.65 0.00%
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.38
Design Therapeutics earnings summary
Design Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.38.
Summary generated from market data by MetaCap's automated system. Methodology